Predicting disease progression in behavioral variant frontotemporal dementia.

behavioral variant frontotemporal dementia brain volume classification models disease progression frontotemporal dementia prognosis

Journal

Alzheimer's & dementia (Amsterdam, Netherlands)
ISSN: 2352-8729
Titre abrégé: Alzheimers Dement (Amst)
Pays: United States
ID NLM: 101654604

Informations de publication

Date de publication:
2021
Historique:
received: 15 03 2021
revised: 24 09 2021
accepted: 01 10 2021
entrez: 10 1 2022
pubmed: 11 1 2022
medline: 11 1 2022
Statut: epublish

Résumé

The behavioral variant of frontotemporal dementia (bvFTD) is a rare neurodegenerative disease. Reliable predictors of disease progression have not been sufficiently identified. We investigated multivariate magnetic resonance imaging (MRI) biomarker profiles for their predictive value of individual decline. One hundred five bvFTD patients were recruited from the German frontotemporal lobar degeneration (FTLD) consortium study. After defining two groups ("fast progressors" vs. "slow progressors"), we investigated the predictive value of MR brain volumes for disease progression rates performing exhaustive screenings with multivariate classification models. We identified areas that predict disease progression rate within 1 year. Prediction measures revealed an overall accuracy of 80% across our 50 top classification models. Especially the pallidum, middle temporal gyrus, inferior frontal gyrus, cingulate gyrus, middle orbitofrontal gyrus, and insula occurred in these models. Based on the revealed marker combinations an individual prognosis seems to be feasible. This might be used in clinical studies on an individualized progression model.

Identifiants

pubmed: 35005196
doi: 10.1002/dad2.12262
pii: DAD212262
pmc: PMC8719425
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e12262

Informations de copyright

© 2021 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, LLC on behalf of Alzheimer's Association.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Références

JAMA Neurol. 2016 Sep 1;73(9):1078-88
pubmed: 27429218
Brain. 2014 Jun;137(Pt 6):1621-6
pubmed: 24740987
Neuroimage. 2010 Feb 1;49(3):2216-24
pubmed: 19878722
Brain Struct Funct. 2010 Jun;214(5-6):579-91
pubmed: 20428887
Ann N Y Acad Sci. 2007 Dec;1121:528-45
pubmed: 17846163
Neuroimage. 2006 Jul 1;31(3):968-80
pubmed: 16530430
Hum Brain Mapp. 2012 Jul;33(7):1526-35
pubmed: 21618662
Dementia. 1995 Jul-Aug;6(4):195-9
pubmed: 7550598
Lancet Neurol. 2015 Mar;14(3):253-62
pubmed: 25662776
Brain. 2019 Feb 1;142(2):443-459
pubmed: 30698757
Ann N Y Acad Sci. 2011 Apr;1225:59-71
pubmed: 21534993
Brain. 2008 Nov;131(Pt 11):2957-68
pubmed: 18829698
Hum Brain Mapp. 2016 Dec;37(12):4472-4486
pubmed: 27510944
Arch Neurol. 2008 Feb;65(2):249-55
pubmed: 18268196
J Alzheimers Dis. 2019;68(3):1229-1241
pubmed: 30909224
Neurology. 2018 Oct 9;91(15):e1390-e1401
pubmed: 30209235
Nervenarzt. 2011 Aug;82(8):1002-5
pubmed: 21805118
Brain. 2011 Sep;134(Pt 9):2456-77
pubmed: 21810890
Neuropsychiatr Dis Treat. 2019 Feb 20;15:557-573
pubmed: 30863078
Alzheimers Dement. 2010 May;6(3):212-20
pubmed: 20451869
Cortex. 2014 Aug;57:22-37
pubmed: 24763126
J Geriatr Psychiatry Neurol. 2013 Dec;26(4):221-9
pubmed: 23904354
Arch Sex Behav. 2013 Apr;42(3):501-9
pubmed: 23297146
Neurology. 2009 Nov 3;73(18):1443-50
pubmed: 19884571
Mov Disord. 2016 Oct;31(10):1506-1517
pubmed: 27452874
J Neurol. 2019 Feb;266(2):330-338
pubmed: 30506397
Neuroimage. 2008 Feb 1;39(3):1064-80
pubmed: 18037310
Behav Brain Res. 2009 Jan 23;196(2):155-67
pubmed: 18955088
Curr Opin Neurol. 2011 Dec;24(6):542-9
pubmed: 21986680
JAMA Neurol. 2015 Dec;72(12):1501-9
pubmed: 26501846
Cogn Behav Neurol. 2008 Jun;21(2):104-6
pubmed: 18541987
Ann Neurol. 2020 Jul;88(1):113-122
pubmed: 32285980

Auteurs

Sarah Anderl-Straub (S)

Department of Neurology University of Ulm Ulm Germany.

Ludwig Lausser (L)

Institute of Medical Systems Biology University of Ulm Ulm Germany.

Jolina Lombardi (J)

Department of Neurology University of Ulm Ulm Germany.

Ingo Uttner (I)

Department of Neurology University of Ulm Ulm Germany.

Klaus Fassbender (K)

Department of Neurology Saarland University Homburg Germany.

Klaus Fliessbach (K)

Clinic for Neurodegenerative Diseases and Geriatric Psychiatry University Hospital Bonn Bonn Germany.

Hans-Jürgen Huppertz (HJ)

Swiss Epilepsy Clinic Zurich Switzerland.

Holger Jahn (H)

Department of Psychiatry and Psychotherapy University Hospital Hamburg Eppendorf Hamburg Germany.

Johannes Kornhuber (J)

Department of Psychiatry and Psychotherapy University Erlangen Erlangen Germany.

Hellmuth Obrig (H)

Max-Planck-Institute of Human Cognitive and Brain Sciences & Clinic for Cognitive Neurology University Hospital Leipzig Leipzig Germany.

Anja Schneider (A)

Clinic for Neurodegenerative Diseases and Geriatric Psychiatry University Hospital Bonn Bonn Germany.
German Center for Neurodegenerative Diseases (DZNE) Bonn Germany.

Elisa Semler (E)

Department of Neurology University of Ulm Ulm Germany.

Matthis Synofzik (M)

Department of Neurodegenerative Diseases Center of Neurology and Hertie-Institute for Clinical Brain Research University Tübingen Germany.
German Center for Neurodegenerative Diseases (DZNE) Tübingen Germany.

Adrian Danek (A)

Department of Neurology Ludwig-Maximilians-Universität München Munich Germany.

Johannes Prudlo (J)

Department of Neurology Rostock University Medical Center and German Center for Neurodegenerative Diseases (DZNE) Rostock Germany.

Jan Kassubek (J)

Department of Neurology University of Ulm Ulm Germany.

Bernhard Landwehrmeyer (B)

Department of Neurology University of Ulm Ulm Germany.

Martin Lauer (M)

Department of Psychiatry and Psychotherapy University of Würzburg Würzburg Germany.

Alexander E Volk (AE)

Institute for Human Genetics University Hospital Hamburg Eppendorf Hamburg Germany.

Jens Wiltfang (J)

Department of Psychiatry and Psychotherapy University Medical Center Göttingen (UMG) Göttingen Germany.
German Center for Neurodegenerative Diseases (DZNE) Göttingen Germany.
Neurosciences and Signaling Group Institute of Biomedicine (iBiMED) Department of Medical Sciences University of Aveiro Aveiro Portugal.

Janine Diehl-Schmid (J)

Department of Psychiatry and Psychotherapy Technical University of Munich Munich Germany.

Albert C Ludolph (AC)

Department of Neurology University of Ulm Ulm Germany.

Matthias L Schroeter (ML)

Max-Planck-Institute of Human Cognitive and Brain Sciences & Clinic for Cognitive Neurology University Hospital Leipzig Leipzig Germany.

Hans A Kestler (HA)

Institute of Medical Systems Biology University of Ulm Ulm Germany.

Markus Otto (M)

Department of Neurology University of Ulm Ulm Germany.
Department of Neurology Martin Luther University Halle-Wittenberg University clinic Halle Halle (Saale) Germany.

Classifications MeSH